Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CRISCURIS INC

Nasdaq · CIK 0001108205
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts385

Identity from submissions API

NameCURIS INC
CIK0001108205
TickersCRIS
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN043505116
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-503-6500
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
128 SPRING STREET
BUILDING C, SUITE 500
LEXINGTON
MA
02421
MA
Mailing address
128 SPRING STREET
BUILDING C, SUITE 500
LEXINGTON
MA
02421
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1234 filing rows loaded from submissions recent; extra archives: CIK0001108205-submissions-001.json (234 filings, 2000-03-06 to 2005-09-20).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005217 005-59429 261557930 34 10422
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-127181 005-59429 261553722 34 11749
2026-11-13 S-8 POS S-8 POS 0001104659-26-127173 333-218632 261553659 33 120455
2026-11-13 S-8 POS S-8 POS 0001104659-26-127172 333-291324 261553650 33 120454
2026-11-13 S-8 POS S-8 POS 0001104659-26-127170 333-280208 261553636 33 120454
2026-11-13 S-8 POS S-8 POS 0001104659-26-127168 333-276951 261553627 33 120454
2026-11-13 S-8 POS S-8 POS 0001104659-26-127167 333-267776 261553615 33 120454
2026-11-13 S-8 POS S-8 POS 0001104659-26-127164 333-260278 261553609 33 120454
2026-11-13 S-8 POS S-8 POS 0001104659-26-127162 333-251144 261553581 33 120454
2026-11-13 S-8 POS S-8 POS 0001104659-26-127160 333-235499 261553571 33 120454
2026-11-13 S-8 POS S-8 POS 0001104659-26-127159 333-228811 261553567 33 120454
2026-11-13 S-8 POS S-8 POS 0001104659-26-127155 333-222259 261553562 33 120454
2026-11-13 S-8 POS S-8 POS 0001104659-26-127152 333-215453 261553545 33 120454
2026-11-13 S-8 POS S-8 POS 0001104659-26-127149 333-206323 261553529 33 120454
2026-11-13 S-8 POS S-8 POS 0001104659-26-127146 333-191074 261553515 33 120454
2026-11-13 S-8 POS S-8 POS 0001104659-26-127144 333-167675 261553507 33 120454
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-127115 005-59429 261553215 34 178975
2026-11-13 S-8 FORM S-8 0001104659-26-127091 333-300040 261552937 33 241222 1 1
2026-11-13 S-3 FORM S-3 0001104659-26-127083 333-300039 261552842 33 524133 1 1
2026-11-13 10-Q 10-Q 0001104659-26-127050 000-30347 261552451 34 7261398 1 1
2026-11-13 8-K FORM 8-K 2.02,9.01 0001104659-26-127041 000-30347 261552382 34 264330 1 1
2026-11-10 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-125055 005-59429 261539459 34 8536
2026-11-06 8-K FORM 8-K 3.01 0001104659-26-123906 000-30347 261532467 34 190390 1 1
2026-11-02 DEF 14A DEF 14A 0001140361-26-041419 000-30347 261509948 34 2317637
2026-10-23 PRE 14A PRE 14A 0001140361-26-040582 000-30347 261479896 34 1332025
2026-10-19 8-K FORM 8-K 1.01,3.02,9.01 0001104659-26-116910 000-30347 261469433 34 981910 1 1
2026-08-14 10-Q 10-Q 0001108205-26-000118 000-30347 261280992 34 6588931 1 1
2026-08-13 424B4 424B4 0001108205-26-000116 333-298203 261275065 33 449248
2026-08-12 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002653 333-298203 261269674 33 1767
2026-08-10 S-1 S-1 0001108205-26-000109 333-298203 261259739 33 1727376 1 1
2026-07-30 8-K 8-K 3.01 0001108205-26-000105 000-30347 261223181 34 149045 1 1
2026-07-17 DRS filename1.htm 0001108205-26-000101 377-09584 261183733 33 686752
2026-07-09 4 FORM 4 0001108205-26-000096 312946
2026-07-09 4 FORM 4 0001108205-26-000095 313343
2026-07-09 4 FORM 4 0001108205-26-000094 313383
2026-07-09 4 FORM 4 0001108205-26-000093 313607
2026-07-09 4 FORM 4 0001108205-26-000092 313950
2026-07-09 4 FORM 4 0001108205-26-000091 313250
2026-07-09 4 FORM 4 0001108205-26-000090 313504
2026-07-09 4 FORM 4 0001108205-26-000089 313400
2026-07-02 8-K 8-K 3.03,5.03,9.01 0001108205-26-000078 000-30347 261147951 34 168214 1 1
2026-07-01 8-K/A 8-K/A 5.03 0001108205-26-000076 000-30347 261143422 34 147568 1 1
2026-07-01 8-K 8-K 5.03 0001108205-26-000074 000-30347 261142690 34 146756 1 1
2026-06-25 8-K 8-K 5.07 0001108205-26-000071 000-30347 261121830 34 149719 1 1
2026-06-05 DEF 14A DEF 14A 0001108205-26-000068 000-30347 261067034 34 1331360
2026-05-22 PRE 14A PRE 14A 0001108205-26-000066 000-30347 261014965 34 1333222
2026-05-22 8-K 8-K 3.03,5.03,5.07,9.01 0001108205-26-000065 000-30347 261013543 34 204237 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002137 005-59429 26984073 34 10571
2026-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-061026 005-59429 26977990 34 10165
2026-05-13 10-Q 10-Q 0001108205-26-000061 000-30347 26971289 34 5102486 1 1
2026-05-12 8-K 8-K 2.02,9.01 0001108205-26-000059 000-30347 26968303 34 247924 1 1
2026-05-01 8-K 8-K 3.01 0001108205-26-000056 000-30347 26932337 34 149581 1 1
2026-04-24 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-048774 005-59429 26896160 34 12076
2026-04-21 ARS ARS 0001108205-26-000054 000-30347 26880263 34 19981206
2026-04-21 DEF 14A DEF 14A 0001108205-26-000053 000-30347 26880255 34 3197190 1 1
2026-04-10 PRE 14A PRE 14A 0001108205-26-000049 000-30347 26855141 34 3201170 1 1
2026-04-07 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-040431 005-59429 26845397 34 11762
2026-04-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-040429 005-59429 26845367 34 7822
2026-04-01 4 FORM 4 0001108205-26-000045 4636
2026-03-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000935836-26-000184 005-59429 26809420 34 18857
2026-03-24 10-K 10-K 0001108205-26-000043 000-30347 26787231 34 8282939 1 1
2026-03-23 4 FORM 4 0001108205-26-000040 7678
2026-03-23 4 FORM 4 0001108205-26-000039 7626
2026-03-23 4 FORM 4 0001108205-26-000038 7659
2026-03-23 4 FORM 4 0001108205-26-000037 7687
2026-03-23 4 FORM 4 0001108205-26-000036 7631
2026-03-20 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000885 333-293470 26779742 33 1766
2026-03-19 8-K 8-K 2.02,9.01 0001108205-26-000030 000-30347 26774331 34 267425 1 1
2026-03-18 4 FORM 4 0001108205-26-000028 13801
2026-03-18 4 FORM 4 0001108205-26-000027 13749
2026-03-18 4 FORM 4 0001108205-26-000026 13784
2026-03-18 4 FORM 4 0001108205-26-000025 13815
2026-03-18 4 FORM 4 0001108205-26-000024 13754
2026-03-17 8-K 8-K 3.03,5.02,5.03,5.07,9.01 0001108205-26-000016 000-30347 26763124 34 330448 1 1
2026-03-17 CORRESP filename1.htm 0001108205-26-000013 52130
2026-02-19 DEF 14A DEF 14A 0001108205-26-000011 000-30347 26654533 34 1601174
2026-02-19 UPLOAD filename1.pdf 0000000000-26-001698 333-293470 40079
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001260 005-59429 26645121 34 10541
2026-02-13 S-3 S-3 0001108205-26-000009 333-293470 26633230 33 652074 1 1
2026-02-09 PRE 14A PRE 14A 0001108205-26-000007 000-30347 26612260 34 1586833
2026-02-09 8-K 8-K 3.01 0001108205-26-000006 000-30347 26612254 34 148651 1 1
2026-01-23 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-000428 005-59429 26556592 34 11243
2026-01-08 8-K 8-K 1.01,3.02,5.03,8.01,9.01 0001108205-26-000002 000-30347 26517019 34 1404515 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001012975-25-000772 005-59429 251487017 34 11978
2025-11-13 8-K/A 8-K/A 9.01 0001108205-25-000111 000-30347 251479761 34 285367 1 1
2025-11-06 S-8 S-8 0001108205-25-000109 333-291324 251458836 33 334467 1 1
2025-11-06 10-Q 10-Q 0001108205-25-000107 000-30347 251458300 34 5118893 1 1
2025-11-06 8-K 8-K 1.02,2.01,2.02,8.01,9.01 0001108205-25-000105 000-30347 251458039 34 283989 1 1
2025-10-24 8-K 8-K 3.01 0001108205-25-000098 000-30347 251416153 34 147000 1 1
2025-08-22 8-K 8-K 3.01 0001108205-25-000093 000-30347 251246256 34 146549 1 1
2025-08-18 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002667 333-289456 251229559 33 1767
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003619 005-59429 251222228 34 10540
2025-08-14 CORRESP filename1.htm 0001108205-25-000091 176925
2025-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003555 005-59429 251211255 34 11000
2025-08-13 UPLOAD filename1.pdf 0000000000-25-008498 333-289456 40104
2025-08-11 S-1 S-1 0001108205-25-000089 333-289456 251199590 33 733781 1 1
2025-08-08 8-K 8-K 8.01,9.01 0001108205-25-000087 000-30347 251199559 34 253560 1 1
2025-08-08 424B5 424B5 0001108205-25-000086 333-276950 251199557 33 336193
2025-08-05 10-Q 10-Q 0001108205-25-000080 000-30347 251182934 34 5099243 1 1
2025-08-05 8-K 8-K 2.02,9.01 0001108205-25-000079 000-30347 251182898 34 263209 1 1
2025-07-02 424B5 424B5 0001108205-25-000076 333-276950 251102703 33 422788
2025-07-02 FWP FWP 0001108205-25-000075 333-276950 251102186 34 39209
2025-07-02 8-K 8-K 1.01,3.02,7.01,8.01,9.01 0001108205-25-000072 000-30347 251098433 34 5290057 1 1
2025-05-22 4 FORM 4 0001108205-25-000069 6236
2025-05-22 4 FORM 4 0001108205-25-000068 6070
2025-05-22 4 FORM 4 0001108205-25-000067 6017
2025-05-22 4 FORM 4 0001108205-25-000066 6070
2025-05-22 4 FORM 4 0001108205-25-000065 6230
2025-05-22 4 FORM 4 0001108205-25-000064 6062
2025-05-22 4 FORM 4 0001108205-25-000063 6231
2025-05-22 4 FORM 4 0001108205-25-000062 6079
2025-05-22 8-K 8-K 3.03,5.02,5.03,5.07,9.01 0001108205-25-000053 000-30347 25977023 34 577400 1 1
2025-05-19 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001654 333-287014 25966047 33 1766
2025-05-15 CORRESP filename1.htm 0001108205-25-000050 177055
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002221 005-59429 25951834 34 10415
2025-05-13 UPLOAD filename1.pdf 0000000000-25-005110 333-287014 40088
2025-05-07 S-3 S-3 0001108205-25-000048 333-287014 25918718 33 387984
2025-05-06 10-Q 10-Q 0001108205-25-000046 000-30347 25915319 34 4685079 1 1
2025-05-06 8-K 8-K 2.02,9.01 0001108205-25-000045 000-30347 25915312 34 254978 1 1
2025-05-05 4 FORM 4 0001108205-25-000042 5476
2025-05-05 3 FORM 3 0001108205-25-000041 10130
2025-04-16 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-035580 005-59429 25843713 34 9554
2025-04-10 ARS ARS 0001108205-25-000038 000-30347 25828751 34 19799602
2025-04-10 DEFA14A DEFA14A 0001108205-25-000037 000-30347 25828744 34 1439808
2025-04-10 DEF 14A DEF 14A 0001108205-25-000036 000-30347 25828726 34 2030896 1 1
2025-03-31 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001420506-25-000715 005-59429 25795837 34 17330
2025-03-31 PRE 14A PRE 14A 0001108205-25-000032 000-30347 25795058 34 2052757 1 1
2025-03-31 10-K 10-K 0001108205-25-000031 000-30347 25793078 34 8084707 1 1
2025-03-31 8-K 8-K 2.02,9.01 0001108205-25-000028 000-30347 25789006 34 271291 1 1
2025-03-31 424B5 424B5 0001108205-25-000026 333-276950 25788635 33 430263
2025-03-31 FWP FWP 0001108205-25-000024 333-276950 25788189 34 495569
2025-03-28 8-K 8-K 1.01,2.02,3.02,8.01,9.01 0001108205-25-000022 000-30347 25781562 34 1072711 1 1
2025-02-27 8-K 8-K 3.01 0001108205-25-000020 000-30347 25678570 34 152399 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-021205 005-59429 25628896 34 12144
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-011844 005-59429 25612049 34 7934
2025-01-30 4 FORM 4 0001108205-25-000018 5453
2025-01-30 4 FORM 4 0001108205-25-000016 5459
2025-01-30 4 FORM 4 0001108205-25-000014 5454
2025-01-30 4 FORM 4 0001108205-25-000012 5302
2025-01-30 4 FORM 4 0001108205-25-000010 5293
2025-01-30 4 FORM 4 0001108205-25-000008 5285
2025-01-30 4 FORM 4 0001108205-25-000006 5293
2025-01-30 4 FORM 4 0001108205-25-000004 5240
2025-01-07 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000047 333-284009 25516413 33 1773
2025-01-03 CORRESP filename1.htm 0001108205-25-000002 176373
2024-12-31 UPLOAD filename1.pdf 0000000000-24-014350 333-284009 40114
2024-12-23 S-3 S-3 0001108205-24-000074 333-284009 241570204 33 444860
2024-11-14 10-Q 10-Q 0001108205-24-000072 000-30347 241457317 34 5021364 1 1
2024-11-14 8-K 8-K 2.02,9.01 0001108205-24-000071 000-30347 241457310 34 276085 1 1
2024-11-13 SC 13G/A d11528364_13g-a.htm 0000919574-24-006370 005-59429 241453119 34 138306
2024-11-01 SC 13G SCHEDULE 13G 0001104659-24-113528 005-59429 241419542 34 43202
2024-10-30 424B5 424B5 0001108205-24-000067 333-276950 241407295 33 392809
2024-10-30 8-K 8-K 1.01,3.02,8.01,9.01 0001108205-24-000068 000-30347 241407179 34 987968 1 1
2024-10-29 FWP FWP 0001108205-24-000065 333-276950 241402412 34 25042
2024-08-01 10-Q 10-Q 0001108205-24-000062 000-30347 241164459 34 4808388 1 1
2024-08-01 8-K 8-K 2.02,9.01 0001108205-24-000061 000-30347 241164449 34 263734 1 1
2024-06-14 S-8 S-8 0001108205-24-000057 333-280208 241044646 33 189339
2024-05-23 4 FORM 4 0001108205-24-000055 6364
2024-05-23 4 FORM 4 0001108205-24-000054 6373
2024-05-23 4 FORM 4 0001108205-24-000053 6365
2024-05-23 4 FORM 4 0001108205-24-000052 6024
2024-05-23 4 FORM 4 0001108205-24-000051 6015
2024-05-23 4 FORM 4 0001108205-24-000050 6007
2024-05-23 4 FORM 4 0001108205-24-000049 6015
2024-05-23 4 FORM 4 0001108205-24-000048 5962
2024-05-23 8-K 8-K 3.03,5.02,5.03,5.07,8.01,9.01 0001108205-24-000047 000-30347 24978191 34 598296 1 1
2024-05-14 8-K 8-K 7.01,8.01,9.01 0001108205-24-000035 000-30347 24944176 34 6014424 1 1
2024-05-07 10-Q 10-Q 0001108205-24-000033 000-30347 24919774 34 4312724 1 1
2024-05-07 8-K 8-K 2.02 0001108205-24-000032 000-30347 24919695 34 252469 1 1
2024-04-15 SC 13G d11024085_13g.htm 0000919574-24-002538 005-59429 24844210 34 139762
2024-04-12 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-04-12 16:30:00 9999999995-24-000952 333-276950 24842996 33 1773
2024-04-10 CORRESP filename1.htm 0001108205-24-000028 176781
2024-04-10 ARS ARS 0001108205-24-000027 000-30347 24835999 34 18328652
2024-04-10 DEFA14A DEFA14A 0001108205-24-000026 000-30347 24835981 34 323272
2024-04-10 DEF 14A DEF 14A 0001108205-24-000025 000-30347 24835968 34 1533932
2024-03-29 PRE 14A PRE 14A 0001108205-24-000018 000-30347 24802493 34 1539527
2024-02-14 SC 13G/A SC 13G/A 0001193125-24-036515 005-59429 24640054 34 79377
2024-02-13 UPLOAD filename1.pdf 0000000000-24-001704 333-276950 40297
2024-02-12 SC 13G CURIS, INC. 0000902664-24-001427 005-59429 24620122 34 67824
2024-02-08 S-8 S-8 0001108205-24-000016 333-276951 24609680 33 180089
2024-02-08 S-3 S-3 0001108205-24-000014 333-276950 24609482 33 840971
2024-02-08 10-K 10-K 0001108205-24-000010 000-30347 24608915 34 7396391 1 1
2024-02-08 8-K 8-K 2.02,9.01 0001108205-24-000008 000-30347 24606910 34 264620 1 1
2024-01-11 8-K 8-K 7.01,9.01 0001108205-24-000003 000-30347 24528021 34 2694274 1 1
2024-01-03 UPLOAD filename1.pdf 0000000000-24-000080 39635
2023-12-21 CORRESP filename1.htm 0001108205-23-000078 24457
2023-12-21 10-K/A 10-K/A 0001108205-23-000077 000-30347 231505210 34 452627 1 1
2023-12-12 UPLOAD filename1.pdf 0000000000-23-013529 42752
2023-11-02 10-Q 10-Q 0001108205-23-000074 000-30347 231370175 34 4745093 1 1
2023-11-02 8-K 8-K 2.02 0001108205-23-000073 000-30347 231370164 34 264938 1 1
2023-09-28 8-K/A 8-K/A 3.03,5.03,5.07,9.01 0001108205-23-000069 000-30347 231289519 34 208694 1 1
2023-09-28 8-K 8-K 5.07,9.01 0001108205-23-000066 000-30347 231286320 34 202950 1 1
2023-08-18 DEF 14A DEF 14A 0001108205-23-000064 000-30347 231185831 34 547209
2023-08-04 PRE 14A PRE 14A 0001108205-23-000062 000-30347 231144094 34 544084
2023-08-03 10-Q 10-Q 0001108205-23-000060 000-30347 231139811 34 4648153 1 1
2023-08-03 8-K 8-K 2.02 0001108205-23-000059 000-30347 231139761 34 265583 1 1
2023-07-06 424B5 424B5 0001193125-23-182799 333-254362 231073994 33 436171
2023-07-06 8-K 8-K 1.01,8.01,9.01 0001108205-23-000056 000-30347 231072260 34 12426035 1 1
2023-07-06 8-K 8-K 7.01,8.01,9.01 0001108205-23-000054 000-30347 231072128 34 2781604 1 1
2023-05-30 8-K 8-K 5.07 0001108205-23-000051 000-30347 23976318 34 193281 1 1
2023-05-04 10-Q 10-Q 0001108205-23-000049 000-30347 23888544 34 4488034 1 1
2023-05-04 8-K 8-K 2.02,9.01 0001108205-23-000048 000-30347 23888475 34 275677 1 1
2023-05-03 4 FORM 4 0001108205-23-000046 8729
2023-05-03 3 FORM 3 0001108205-23-000045 6549
2023-04-26 8-K 8-K 3.01 0001108205-23-000040 000-30347 23849648 34 176952 1 1
2023-04-11 ARS ARS 0001108205-23-000037 000-30347 23813787 34 18728926
2023-04-11 DEFA14A DEFA14A 0001108205-23-000036 000-30347 23813783 34 1279641
2023-04-11 DEF 14A DEF 14A 0001108205-23-000035 000-30347 23813771 34 1916468
2023-03-13 10-K 10-K 0001108205-23-000023 000-30347 23725776 34 8124317 1 1
2023-03-13 8-K 8-K 2.02,5.03,9.01 0001108205-23-000022 000-30347 23725763 34 608499 1 1
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-037204 005-59429 23622426 34 79926
2023-01-24 4 FORM 4 0001108205-23-000016 8744
2023-01-24 4 FORM 4 0001108205-23-000015 8734
2023-01-24 4 FORM 4 0001108205-23-000014 8728
2023-01-24 4 FORM 4 0001108205-23-000013 8684
2023-01-24 4 FORM 4 0001108205-23-000012 5395
2023-01-24 4 FORM 4 0001108205-23-000011 5381
2023-01-24 4 FORM 4 0001108205-23-000010 8682
2023-01-24 4 FORM 4 0001108205-23-000009 8721
2023-01-20 SC 13G/A Curis_Inc.txt 0000093751-23-000027 005-59429 23539392 34 8204
2022-11-09 10-Q 10-Q 0001108205-22-000023 000-30347 221373503 34 5712615 1 1
2022-11-09 8-K 8-K 2.02,9.01 0001108205-22-000022 000-30347 221372441 34 300302 1 1
2022-10-26 8-K 8-K 3.01 0001108205-22-000018 000-30347 221333272 34 180877 1 1
2022-10-14 4 FORM 4 SUBMISSION 0001209191-22-053658 5642
2022-10-14 3 FORM 3 SUBMISSION 0001209191-22-053657 6326
2022-10-14 8-K 8-K 5.02,9.01 0001108205-22-000016 000-30347 221311329 34 186674 1 1
2022-10-07 S-8 S-8 0001108205-22-000014 333-267776 221300780 33 181876
2022-09-22 8-K 8-K 5.02 0001108205-22-000012 000-30347 221259256 34 186575 1 1
2022-08-30 8-K 8-K 8.01,9.01 0001193125-22-233468 000-30347 221212914 34 187933 1 1
2022-08-18 8-K 8-K 8.01,9.01 0001193125-22-223699 000-30347 221176345 34 184340 1 1
2022-08-10 3 FORM 3 SUBMISSION 0001209191-22-045172 7524
2022-08-04 10-Q 10-Q 0001108205-22-000009 000-30347 221136464 34 5324850 1 1
2022-08-04 8-K 8-K 2.02,5.02,9.01 0001193125-22-212487 000-30347 221136377 34 251873 1 1
2022-07-08 SC 13G us2312692005_070822.txt 0000834237-22-010292 005-59429 221075048 34 12223
2022-06-30 8-K 8-K 5.02 0001193125-22-186157 000-30347 221058079 34 148985 1 1
2022-06-02 8-K 8-K 5.07 0001193125-22-166212 000-30347 22990804 34 155302 1 1
2022-05-05 10-Q 10-Q 0001108205-22-000005 000-30347 22897053 34 4965531 1 1
2022-05-05 8-K 8-K 2.02,9.01 0001564590-22-018292 000-30347 22896985 34 304372 1 1
2022-04-14 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-22-052364,2022-04-14 9999999995-22-000976 333-254362 22828886 33 1737
2022-04-13 DEFA14A DEFA14A 0001193125-22-104352 000-30347 22825025 34 1001864
2022-04-13 DEF 14A DEF 14A 0001193125-22-104344 000-30347 22825012 34 638516
2022-04-11 8-K 8-K 8.01,9.01 0001193125-22-101017 000-30347 22818518 34 183945 1 1
2022-04-04 8-K 8-K 8.01,9.01 0001193125-22-094363 000-30347 22800366 34 183066 1 1
2022-02-24 POS AM POS AM 0001193125-22-052364 333-254362 22672438 33 558558
2022-02-24 10-K 10-K 0001108205-22-000002 000-30347 22671651 34 10211563 1 1
2022-02-24 POSASR POSASR 0001193125-22-052045 333-254362 22670917 33 703551
2022-02-24 8-K 8-K 2.02,9.01 0001564590-22-006690 000-30347 22670900 34 353722 1 1
2022-02-14 SC 13G/A SCHEDULE 13G (AMENDMENT NO. 1) 0000899140-22-000333 005-59429 22633515 34 67762
2022-02-14 SC 13G SC 13G 0001193125-22-041235 005-59429 22629851 34 81214
2022-02-11 SC 13G CURIS_INC.txt 0000093751-22-000240 005-59429 22617201 34 10234
2022-02-10 SC 13G/A AMENDMENT NO. 1 0001214659-22-002185 005-59429 22613834 34 43568
2022-02-10 SC 13G/A CURIS, INC. 0000902664-22-001354 005-59429 22611456 34 101760
2022-02-04 SC 13G us2312692005_020422.txt 0000834237-22-007334 005-59429 22593598 34 13258
2022-02-02 8-K 8-K 1.01,2.03,9.01 0001193125-22-025755 000-30347 22584121 34 334634 1 1
2022-01-31 4 FORM 4 SUBMISSION 0001209191-22-005691 5436
2022-01-31 4 FORM 4 SUBMISSION 0001209191-22-005689 5427
2022-01-31 4 FORM 4 SUBMISSION 0001209191-22-005688 5445
2022-01-31 4 FORM 4 SUBMISSION 0001209191-22-005686 5436
2022-01-31 4 FORM 4 SUBMISSION 0001209191-22-005685 5383
2022-01-31 4 FORM 4 SUBMISSION 0001209191-22-005663 5436
2022-01-31 4 FORM 4 SUBMISSION 0001209191-22-005660 5425
2022-01-31 4 FORM 4 SUBMISSION 0001209191-22-005651 9033
2022-01-07 8-K/A 8-K/A 5.02 0001193125-22-004426 000-30347 22518143 34 149912 1 1
2022-01-06 8-K 8-K 7.01,8.01,9.01 0001193125-22-003127 000-30347 22513618 34 16267718 1 1
2021-12-06 4 FORM 4 SUBMISSION 0001209191-21-068030 5656
2021-12-06 3 FORM 3 SUBMISSION 0001209191-21-068029 6332
2021-12-06 8-K 8-K 5.02,8.01,9.01 0001193125-21-348468 000-30347 211472046 34 183534 1 1
2021-11-15 SC 13G/A SCHEDULE 13G/A 0001104659-21-139242 005-59429 211411455 34 76650
2021-11-09 10-Q 10-Q 0001108205-21-000012 000-30347 211392982 34 6014776 1 1
2021-11-09 8-K 8-K 2.02,9.01 0001564590-21-055786 000-30347 211392873 34 351478 1 1
2021-10-15 S-8 S-8 0001193125-21-300006 333-260278 211326065 33 157335
2021-08-03 10-Q 10-Q 0001108205-21-000009 000-30347 211139832 34 5737694 1 1
2021-08-03 8-K 8-K 2.02,9.01 0001564590-21-040222 000-30347 211139722 34 352628 1 1
2021-06-16 CT ORDER filename1.pdf 20210616,20210616 9999999997-21-003426 000-30347 211020492 34 119114
2021-06-11 8-K 8-K 8.01,9.01 0001564590-21-032550 000-30347 211009941 34 235308 1 1
2021-06-02 8-K 8-K 3.03,5.02,5.03,5.07,9.01 0001193125-21-179839 000-30347 21989117 34 296458 1 1
2021-05-12 10-Q 10-Q 0001108205-21-000006 000-30347 21915217 34 5288047 1 1
2021-05-12 8-K 8-K 2.02,9.01 0001564590-21-026975 000-30347 21915006 34 309374 1 1
2021-04-14 DEFA14A DEFA14A 0001193125-21-116345 000-30347 21826084 34 1053495
2021-04-14 DEF 14A DEF 14A 0001193125-21-116336 000-30347 21826058 34 837941
2021-04-02 PRE 14A PRE 14A 0001193125-21-105179 000-30347 21802342 34 837945
2021-03-22 SC 13G SCHEDULE 13G 0000899140-21-000381 005-59429 21761997 34 61847
2021-03-16 S-3ASR S-3ASR 0001193125-21-083010 333-254362 21746987 33 1567872
2021-03-16 10-K 10-K 0001108205-21-000003 000-30347 21745652 34 9884903 1 1
2021-03-16 8-K 8-K 2.02,9.01 0001564590-21-013557 000-30347 21745614 34 368729 1 1
2021-02-16 SC 13G SC 13G 0001104659-21-024258 005-59429 21639686 34 87847
2021-02-16 SC 13G CRIS 0001214659-21-001841 005-59429 21635315 34 51578
2021-02-11 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-21-000326 005-59429 21620393 34 279206
2021-02-01 SC 13G CURIS, INC. 0000902664-21-000714 005-59429 21576786 34 107437
2021-01-29 4 FORM 4 SUBMISSION 0001209191-21-006102 5383
2021-01-29 4 FORM 4 SUBMISSION 0001209191-21-006101 5429
2021-01-29 4 FORM 4 SUBMISSION 0001209191-21-006100 5436
2021-01-29 4 FORM 4 SUBMISSION 0001209191-21-006099 5458
2021-01-29 4 FORM 4 SUBMISSION 0001209191-21-006098 5477
2021-01-29 4 FORM 4 SUBMISSION 0001209191-21-006097 5427
2021-01-29 4 FORM 4 SUBMISSION 0001209191-21-006096 5445
2021-01-26 4 FORM 4 SUBMISSION 0001209191-21-005492 6557
2021-01-06 SC 13G/A SABBY 13G-A CRIS 1.06.21 0001535610-21-000040 005-59429 21509860 34 13053
2020-12-10 8-K 8-K 1.01,8.01,9.01 0001193125-20-314159 000-30347 201379300 34 515996 1 1
2020-12-10 424B5 424B5 0001193125-20-314147 333-224627 201379290 33 437625
2020-12-09 S-3MEF S-3MEF 0001193125-20-313418 333-251211 201377068 33 56827
2020-12-09 8-K 8-K 8.01 0001193125-20-313343 000-30347 201376882 34 149930 1 1
2020-12-09 424B5 424B5 0001193125-20-313082 333-224627 201376784 33 441828
2020-12-08 8-K 8-K 7.01,8.01,9.01 0001193125-20-312239 000-30347 201374396 34 12498185 1 1
2020-12-04 S-8 S-8 0001193125-20-310634 333-251144 201370085 33 80958
2020-11-10 10-Q 10-Q 0001108205-20-000016 000-30347 201301142 34 6594331 1 1
2020-11-10 8-K 8-K 2.02,9.01 0001564590-20-052943 000-30347 201301024 34 352601 1 1
2020-08-04 10-Q 10-Q 0001108205-20-000012 000-30347 201073621 34 7312522 1 1
2020-08-04 8-K 8-K 2.02,9.01 0001564590-20-036108 000-30347 201073274 34 208976
2020-06-22 SC 13G THE SCHEDULE 13G 0000921895-20-001822 005-59429 20979214 34 281151
2020-06-12 424B5 424B5 0001193125-20-167830 333-224627 20961137 33 534602
2020-06-11 8-K 8-K 1.01,8.01,9.01 0001193125-20-166742 000-30347 20957883 34 220198
2020-06-11 SC 13G SABBY 13G CRIS 6.11.20 0001535610-20-000099 005-59429 20956429 34 13250
2020-06-10 8-K 8-K 3.03,5.02,5.03,5.07,9.01 0001193125-20-165678 000-30347 20954735 34 143410
2020-05-12 10-Q 10-Q 0001108205-20-000007 000-30347 20869280 34 5338126 1
2020-05-12 8-K 8-K 2.02,9.01 0001564590-20-024649 000-30347 20869041 34 162253
2020-04-27 8-K 8-K 2.03,3.01 0001193125-20-120939 000-30347 20819989 34 26023
2020-04-22 DEFA14A DEFA14A 0001193125-20-115026 000-30347 20808037 34 84161
2020-04-22 DEF 14A DEF 14A 0001193125-20-115020 000-30347 20808022 34 952455
2020-04-17 8-K 8-K 3.01 0001193125-20-110625 000-30347 20799736 34 19043
2020-04-10 PRE 14A PRE 14A 0001193125-20-103780 000-30347 20786779 34 952414
2020-03-19 10-K 10-K 0001108205-20-000003 000-30347 20728885 34 9136864 1
2020-03-19 8-K 8-K 2.02,9.01 0001564590-20-011802 000-30347 20728804 34 206127
2020-03-06 8-K 8-K 1.01,9.01 0001193125-20-065141 000-30347 20695233 34 199476
2020-03-06 424B5 424B5 0001193125-20-065128 333-224627 20695129 33 381133
2020-03-06 424B5 424B5 0001193125-20-065115 333-224627 20695050 33 3733
2020-03-04 4 FORM 4 SUBMISSION 0001209191-20-016251 5340
2020-03-04 4 FORM 4 SUBMISSION 0001209191-20-016247 5322
2020-03-04 4 FORM 4 SUBMISSION 0001209191-20-016244 5331
2020-03-04 4 FORM 4 SUBMISSION 0001209191-20-016243 5278
2020-03-04 4 FORM 4 SUBMISSION 0001209191-20-016240 5333
2020-03-04 4 FORM 4 SUBMISSION 0001209191-20-016237 5322
2020-03-04 4 FORM 4 SUBMISSION 0001209191-20-016227 5371
2020-02-27 8-K 8-K 1.01,2.02,8.01,9.01 0001193125-20-051106 000-30347 20658544 34 314499
2020-02-27 424B5 424B5 0001193125-20-051103 333-224627 20658541 33 345534
2020-02-14 SC 13G/A curis13ga2019.htm 0000935836-20-000134 005-59429 20617683 34 50676
2020-02-06 8-K 8-K 1.01,8.01,9.01 0001193125-20-026252 000-30347 20581038 34 52698
2020-01-24 4 FORM 4 SUBMISSION 0001209191-20-004918 6461
2020-01-07 8-K 8-K 1.01,9.01 0001193125-20-002601 000-30347 20512115 34 54923
2019-12-13 S-8 S-8 0001193125-19-313884 333-235499 191284621 33 93672
2019-12-06 8-K 8-K 8.01,9.01 0001193125-19-308386 000-30347 191273824 34 281858
2019-12-06 8-K 8-K 1.01,2.03,9.01 0001193125-19-308357 000-30347 191273695 34 1823069
2019-11-05 10-Q 10-Q 0001108205-19-000020 000-30347 191191769 34 6259110 1
2019-11-05 8-K FORM 8-K 2.02,9.01 0001104659-19-059807 000-30347 191191704 34 187367
2019-09-12 4 FORM 4 SUBMISSION 0001209191-19-049285 5415
2019-09-12 8-K 8-K 5.02,8.01,9.01 0001193125-19-243430 000-30347 191089538 34 34102
2019-08-09 10-Q 10-Q 0001108205-19-000013 000-30347 191011388 34 6805358 1
2019-08-06 8-K FORM 8-K 2.02,9.01 0001144204-19-037877 000-30347 191001941 34 156388
2019-05-30 8-K 8-K 3.03,5.02,5.03,5.07,9.01 0001193125-19-161261 000-30347 19866575 34 134390
2019-05-28 4 FORM 4 SUBMISSION 0001209191-19-032974 6139
2019-05-28 4 FORM 4 SUBMISSION 0001209191-19-032970 6087
2019-05-14 10-Q 10-Q 0001108205-19-000008 000-30347 19822866 34 6335086 1
2019-05-14 8-K FORM 8-K 2.02,9.01 0001144204-19-025989 000-30347 19822697 34 137894
2019-04-17 CT ORDER filename1.pdf 20190417,20190417 9999999997-19-002980 000-30347 19752571 34 89025
2019-04-11 DEFA14A DEFA14A 0001193125-19-103353 000-30347 19742872 34 64392
2019-04-11 DEF 14A DEF 14A 0001193125-19-103347 000-30347 19742862 34 920371
2019-04-01 3 FORM 3 SUBMISSION 0001209191-19-022065 12008
2019-03-29 PRE 14A PRE 14A 0001193125-19-092873 000-30347 19717495 34 920343
2019-03-26 10-K 10-K 0001108205-19-000004 000-30347 19705919 34 9214083 1
2019-03-26 8-K FORM 8-K 2.02,9.01 0001144204-19-016005 000-30347 19705545 34 172633
2019-01-25 4 FORM 4 SUBMISSION 0001209191-19-005357 7097
2019-01-25 4 FORM 4 SUBMISSION 0001209191-19-005355 7266
2019-01-25 4 FORM 4 SUBMISSION 0001209191-19-005354 5374
2019-01-25 4 FORM 4 SUBMISSION 0001209191-19-005352 5427
2019-01-25 4 FORM 4 SUBMISSION 0001209191-19-005351 5418
2019-01-25 4 FORM 4 SUBMISSION 0001209191-19-005350 5435
2019-01-23 4 FORM 4 SUBMISSION 0001209191-19-004996 5305
2019-01-23 4 FORM 4 SUBMISSION 0001209191-19-004995 5367
2019-01-23 4 FORM 4 SUBMISSION 0001209191-19-004993 5358
2019-01-23 4 FORM 4 SUBMISSION 0001209191-19-004985 5349
2019-01-09 SC 13G/A curis12311813ga.txt 0001325447-19-000002 005-59429 19516838 34 7025
2019-01-03 8-K FORM 8-K 3.01 0001193125-19-001044 000-30347 19503606 34 16987
2018-12-27 SC 13G crisschedule13g.htm 0000935836-18-000659 005-59429 181254304 34 50882
2018-12-14 S-8 S-8 0001193125-18-349888 333-228811 181235664 33 77872
2018-11-01 10-Q 10-Q 0001108205-18-000017 000-30347 181152030 34 4948292 1
2018-11-01 8-K FORM 8-K 2.02,9.01 0001144204-18-056624 000-30347 181151956 34 142676
2018-09-27 4 FORM 4 SUBMISSION 0001209191-18-052464 5351
2018-09-27 8-K FORM 8-K 5.02 0001193125-18-285716 000-30347 181091422 34 22561
2018-08-02 10-Q 10-Q 0001108205-18-000013 000-30347 18986674 34 4912224 1
2018-08-02 8-K FORM 8-K 2.02,9.01 0001144204-18-041525 000-30347 18986609 34 143041
2018-07-10 SC 13G/A us2312692005_070518.txt 0000215457-18-005903 005-59429 18945955 34 11998
2018-07-10 CT ORDER filename1.pdf 20180709,20180710 9999999997-18-006799 000-30347 18943717 34 15005
2018-06-05 4 FORM 4 SUBMISSION 0001209191-18-035586 5349
2018-05-31 8-K/A FORM 8-K AMENDMENT NO. 1 5.03 0001193125-18-178940 000-30347 18869688 34 15691
2018-05-29 8-K 8-K 3.03,5.03,9.01 0001193125-18-176914 000-30347 18865403 34 38434
2018-05-24 8-K 8-K 5.02,8.01,9.01 0001144204-18-030653 000-30347 18856620 34 23782
2018-05-22 8-K 8-K 8.01,9.01 0001193125-18-170978 000-30347 18853327 34 25604
2018-05-18 8-K 8-K 3.03,5.02,5.03,5.07,9.01 0001193125-18-168094 000-30347 18847455 34 172485
2018-05-17 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2018-05-17 16:30:00 9999999995-18-001281 333-224627 18844972 33 1648
2018-05-17 4 FORM 4 SUBMISSION 0001209191-18-030875 6060
2018-05-17 4 FORM 4 SUBMISSION 0001209191-18-030871 6080
2018-05-17 4 FORM 4 SUBMISSION 0001209191-18-030864 6072
2018-05-15 CORRESP filename1.htm 0001193125-18-164057 6332
2018-05-14 UPLOAD filename1.pdf 0000000000-18-014917 44650
2018-05-03 S-3 S-3 0001193125-18-149532 333-224627 18801814 33 390457
2018-05-03 10-Q 10-Q 0001108205-18-000010 000-30347 18801769 34 4811157 1
2018-05-03 8-K FORM 8-K 2.02,9.01 0001144204-18-024923 000-30347 18801746 34 116356
2018-04-03 DEFA14A DEFA14A 0001193125-18-105582 000-30347 18731419 34 55853
2018-04-03 DEF 14A DEF 14A 0001193125-18-105574 000-30347 18731411 34 926215
2018-03-23 PRE 14A PRE 14A 0001193125-18-092798 000-30347 18708335 34 925066

Latest XBRL company facts

One latest value per concept from companyfacts (385 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 9.51M 2026-11-10 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
dei EntityPublicFloat Entity Public Float USD 24.80M 2025-06-30 2025 FY 10-K 2026-03-24 0001108205-26-000043
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 656,250 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001108205-26-000053
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 928,767 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001108205-26-000053
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 970,809 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001108205-26-000053
ecd PeoTotalCompAmt PeoTotalCompAmt USD 1.66M 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001108205-26-000053
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 9 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001108205-26-000053
ffd NetFeeAmt NetFeeAmt USD 1,765.96 2026-11-10 S-3 2026-11-13 0001104659-26-127083
ffd TtlFeeAmt TtlFeeAmt USD 1,765.96 2026-11-10 S-3 2026-11-13 0001104659-26-127083
ffd TtlOfferingAmt TtlOfferingAmt USD 20.30M 2026-11-10 S-3 2026-11-13 0001104659-26-127083
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-11-10 S-3 2026-11-13 0001104659-26-127083
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-11-10 S-3 2026-11-13 0001104659-26-127083
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 7.47M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 8.04M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 724,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 3.15M 2022-12-31 2022 FY 10-K 2023-03-13 0001108205-23-000023
us-gaap AccruedUtilitiesCurrent Accrued Utilities, Current USD 204,167 2012-12-31 2012 FY 10-K 2013-03-13 0001193125-13-104455
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 851,000 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 0 2024-12-31 2024 FY 10-K 2025-03-31 0001108205-25-000031
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.29B 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.28B 2026-06-30 2026 Q2 10-Q 2026-08-14 0001108205-26-000118
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 526,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD -100,000 2016-01-01 2016-06-30 2017 Q2 10-Q 2017-08-03 0001108205-17-000012
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 585,000 2020-04-01 2020-06-30 2021 Q2 10-Q 2021-08-03 0001108205-21-000009
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 100,000 2024-04-01 2024-06-30 2024 Q2 10-Q 2024-08-01 0001108205-24-000062
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 4.80M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities USD 16.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 1.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001108205-22-000002
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 7.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 24,529 2010-12-01 2018 FY 10-K 2019-03-26 0001108205-19-000004
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001193125-16-484817
us-gaap Assets Assets USD 18.80M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap AssetsCurrent Assets, Current USD 6.92M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 4.27M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001108205-26-000118
us-gaap AssetsFairValueDisclosureNonrecurring Assets, Fair Value Disclosure, Nonrecurring (Deprecated 2018-01-31) USD 0 2016-03-31 2016 Q1 10-Q 2016-05-09 0001193125-16-582810
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 3,000 2023-12-31 2024 FY 10-K 2025-03-31 0001108205-25-000031
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 4,000 2023-12-31 2024 FY 10-K 2025-03-31 0001108205-25-000031
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 29.65M 2023-12-31 2024 FY 10-K 2025-03-31 0001108205-25-000031
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 48.44M 2013-09-30 2013 Q3 10-Q 2013-11-12 0001193125-13-437655
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 0 2017-12-31 2017 FY 10-K 2018-03-08 0001108205-18-000005
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 2,000 2017-12-31 2017 FY 10-K 2018-03-08 0001108205-18-000005
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 21.95M 2017-12-31 2017 FY 10-K 2018-03-08 0001108205-18-000005
us-gaap AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss), Net of Tax (Deprecated 2018-01-31) USD 1,273 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-13 0001193125-14-097662
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value USD 21.94M 2017-12-31 2017 FY 10-K 2018-03-08 0001108205-18-000005
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 29.65M 2023-12-31 2024 FY 10-K 2025-03-31 0001108205-25-000031
us-gaap AvailableForSaleSecuritiesGrossUnrealizedGainLoss Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31) USD 15,737 2012-12-31 2012 FY 10-K 2013-03-13 0001193125-13-104455
us-gaap AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Greater than or Equal to One Year security 0 2017-12-31 2017 FY 10-K 2018-03-08 0001108205-18-000005
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-03 0001108205-21-000009
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 5.01M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 4.27M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001108205-26-000118
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -14.65M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-26 0001108205-19-000004
us-gaap CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 23.74M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-06 0001193125-15-280043
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 5.10M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001108205-26-000118
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 5.56M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -47,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap CertificatesOfDepositAtCarryingValue Certificates of Deposit, at Carrying Value USD 1.00M 2013-12-31 2014 FY 10-K 2015-02-24 0001193125-15-060006
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/Warrant 3.55 2014-06-30 2014 Q2 10-Q 2014-08-07 0001193125-14-300506
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 3.55 2010-01-27 2016 FY 10-K 2017-03-09 0001108205-17-000006
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 1.61M 2010-01-27 2016 FY 10-K 2017-03-09 0001108205-17-000006
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 1.37M 2014-12-31 2014 FY 10-K 2015-02-24 0001193125-15-060006
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 567.51M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 4.10M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 4.10M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap CommonStockValue Common Stock, Value, Issued USD 41,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -40.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 2.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap CostsAndExpenses Costs and Expenses USD 21.46M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001108205-26-000118
us-gaap DebtCurrent Debt, Current USD 6.92M 2018-12-31 2019 FY 10-K 2020-03-19 0001108205-20-000003
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 28.70M 2018-12-31 2019 FY 10-K 2020-03-19 0001108205-20-000003
us-gaap DebtInstrumentIncreaseAccruedInterest Debt Instrument, Increase, Accrued Interest USD 1.59M 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-24 0001193125-15-060006
us-gaap DebtInstrumentPeriodicPaymentPrincipal Debt Instrument, Periodic Payment, Principal USD 929,339 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-07 0001193125-15-176676
us-gaap DebtIssuanceCosts Debt Issuance Cost (Deprecated 2016-01-31) USD 421,715 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-13 0001193125-13-104455
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2023-12-31 2024 FY 10-K 2025-03-31 0001108205-25-000031
us-gaap DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal Debt Securities, Available-for-sale, Change in Present Value, Expense (Reversal) USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001108205-22-000002
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2023-12-31 2024 FY 10-K 2025-03-31 0001108205-25-000031
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 0 2020-09-30 2020 Q3 10-Q 2020-11-10 0001108205-20-000016
us-gaap DeferredCompensationLiabilityCurrent Deferred Compensation Liability, Current USD -955 2010-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089082
us-gaap DeferredFinanceCostsCurrentNet Debt Issuance Costs, Current, Net USD 36,000 2018-12-31 2019 FY 10-K 2020-03-19 0001108205-20-000003
us-gaap DeferredFinanceCostsGross Debt Issuance Costs, Gross USD 0 2018-12-31 2018 FY 10-K 2019-03-26 0001108205-19-000004
us-gaap DeferredFinanceCostsNoncurrentNet Debt Issuance Costs, Noncurrent, Net USD 96,000 2018-12-31 2019 FY 10-K 2020-03-19 0001108205-20-000003
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 511,000 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 0 2016-12-31 2016 FY 10-K 2017-03-09 0001108205-17-000006
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 0 2016-12-31 2016 FY 10-K 2017-03-09 0001108205-17-000006
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 212.32M 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap DeferredTaxAssetsGrossCurrent Deferred Tax Assets, Gross, Current USD 0 2017-12-31 2017 FY 10-K 2018-03-08 0001108205-18-000005
us-gaap DeferredTaxAssetsGrossNoncurrent Deferred Tax Assets, Gross, Noncurrent USD 143.92M 2017-12-31 2017 FY 10-K 2018-03-08 0001108205-18-000005
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 30.68M 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap DeferredTaxAssetsInvestments Deferred Tax Assets, Investments USD 0 2016-12-31 2016 FY 10-K 2017-03-09 0001108205-17-000006
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 511,000 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 123.69M 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsOther Deferred Tax Assets, Tax Credit Carryforwards, Other USD 29.42M 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 18.34M 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap DeferredTaxAssetsTaxDeferredExpense Deferred Tax Assets, Tax Deferred Expense USD 112,000 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 211.81M 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 500,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 16,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001108205-26-000118
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 26,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure Derivative Financial Instruments, Liabilities, Fair Value Disclosure (Deprecated 2013-01-31) USD 2.69M 2012-09-30 2012 Q3 10-Q 2012-11-06 0001193125-12-453634
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 3.81M 2012-03-31 2012 Q1 10-Q 2012-05-10 0001193125-12-224909
us-gaap DirectCostsOfLeasedAndRentedPropertyOrEquipment Direct Costs of Leased and Rented Property or Equipment USD 789,000 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-13 0001193125-13-104455
us-gaap DirectOperatingCostRoyaltyExpense Direct Operating Cost, Royalty Expense (Deprecated 2018-01-31) USD 176,482 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-13 0001193125-13-104455
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -16.77 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.61 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001108205-21-000003
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -16.77 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.575 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-26 0001108205-19-000004
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.057 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.059 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001108205-25-000031
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure -0.044 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001108205-25-000031
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.091 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 1.88M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount Share-based Payment Arrangement, Amount Capitalized USD 2.47M 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-06 0001193125-12-453634
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 4.30M 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 2.70M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001108205-26-000118
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 10.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 252,222 2015-12-31 2015 FY 10-K 2016-02-29 0001193125-16-484817
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 3.04M 2016-03-31 2016 Q1 10-Q 2016-05-09 0001193125-16-582810
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.58 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-13 0001193125-13-104455
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.003 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-13 0001193125-13-104455
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD -10.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances USD 17.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001193125-16-484817
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD -716,786 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-24 0001193125-15-060006
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001108205-22-000002
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 27.19M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-10 0001108205-20-000016
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001108205-22-000023
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 11.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap Goodwill Goodwill USD 8.98M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -4.48M 2013-10-01 2013-12-31 2013 FY 10-K 2014-03-13 0001193125-14-097662
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -0.05 2013-10-01 2013-12-31 2013 FY 10-K 2014-03-13 0001193125-14-097662
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -0.15 2012-10-01 2012-12-31 2013 FY 10-K 2014-03-13 0001193125-14-097662
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -0.15 2012-10-01 2012-12-31 2013 FY 10-K 2014-03-13 0001193125-14-097662
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap IncomeTaxExpenseBenefitContinuingOperationsGovernmentGrants Income Tax (Expense) Benefit, Continuing Operations, Government Grants USD 488,959 2010-01-01 2010-12-31 2012 FY 10-K 2013-03-13 0001193125-13-104455
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 4.35M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -1.59M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 33,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 435,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 692,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 2.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -106,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -475,833 2010-01-01 2010-12-31 2012 FY 10-K 2013-03-13 0001193125-13-104455
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-09 0001108205-17-000006
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -878,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 2.02M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-13 0001108205-23-000023
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -57,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001108205-18-000005
us-gaap IncreaseDecreaseInSecurityDeposits Increase (Decrease) in Security Deposits USD 41,632 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-13 0001193125-13-104455
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 1.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 5.41M 2012-01-01 2012-03-31 2013 Q1 10-Q 2013-05-09 0001193125-13-210189
us-gaap InterestCostsCapitalized Interest Costs Capitalized USD 713,968 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-10 0001193125-14-404759
us-gaap InterestCostsIncurredCapitalized Capitalized Interest Costs, Including Allowance for Funds Used During Construction USD 0 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-10 0001193125-14-404759
us-gaap InterestExpense Interest Expense USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001108205-22-000002
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 2.32M 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-04 0001108205-20-000012
us-gaap InterestPaidCapitalized Interest Paid, Capitalized, Investing Activities USD 713,968 2014-01-01 2014-09-30 2015 Q3 10-Q 2015-11-09 0001193125-15-371270
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 1.53M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2019-12-31 2019 FY 10-K 2020-03-19 0001108205-20-000003
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 167,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 164,269 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-08 0001193125-13-326082
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 900,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-19 0001108205-20-000003
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 1.72M 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 433,000 2021-12-31 2021 FY 10-K 2022-02-24 0001108205-22-000002
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.29M 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.29M 2021-12-31 2021 FY 10-K 2022-02-24 0001108205-22-000002
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.25M 2021-12-31 2021 FY 10-K 2022-02-24 0001108205-22-000002
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 433,000 2024-12-31 2024 FY 10-K 2025-03-31 0001108205-25-000031
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 433,000 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 272,000 2020-09-30 2020 Q3 10-Q 2020-11-10 0001108205-20-000016
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 102,000 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap Liabilities Liabilities USD 16.25M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 18.80M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap LiabilitiesCurrent Liabilities, Current USD 16.25M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 600,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001108205-26-000118
us-gaap LiabilitiesFairValueDisclosureNonrecurring Liabilities, Fair Value Disclosure, Nonrecurring (Deprecated 2018-01-31) USD 0 2016-03-31 2016 Q1 10-Q 2016-05-09 0001193125-16-582810
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-09 0001108205-17-000006
us-gaap LongTermDebt Long-term Debt USD 900,000 2020-04-30 2022 FY 10-K 2023-03-13 0001108205-23-000023
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 0 2021-09-30 2021 Q3 10-Q 2021-11-09 0001108205-21-000012
us-gaap LongTermInvestments Long-term Investments USD 0 2022-12-31 2022 FY 10-K 2023-03-13 0001108205-23-000023
us-gaap LossesGainsOnSalesOfAssetsAndAssetImpairmentCharges Losses (Gains) on Sales of Assets and Asset Impairment Charges (Deprecated 2012-01-31) USD 1,071 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089082
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-31 0001108205-25-000031
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -229,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 24.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -1.81M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001108205-18-000010
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001108205-26-000118
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -1.77M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001108205-18-000010
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -24.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -9.96M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001108205-18-000010
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -40.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap NoncurrentAssets Long-Lived Assets USD 3.68M 2012-12-31 2012 FY 10-K 2013-03-13 0001193125-13-104455
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -10.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap NumberOfReportingUnits Number of Reporting Units segment 1 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001108205-22-000002
us-gaap OperatingExpenses Operating Expenses USD 30.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -30.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 700,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 740,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 428,000 2025-12-31 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 853,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 9.30M 2021-06-30 2021 Q2 10-Q 2021-08-03 0001108205-21-000009
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 1.00M 2018-12-31 2019 FY 10-K 2020-03-19 0001108205-20-000003
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 59,000 2013-12-31 2013 FY 10-K 2014-03-13 0001193125-14-097662
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 59,000 2014-12-31 2014 FY 10-K 2015-02-24 0001193125-15-060006
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 168,000 2017-12-31 2017 FY 10-K 2018-03-08 0001108205-18-000005
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 168,000 2018-12-31 2019 FY 10-K 2020-03-19 0001108205-20-000003
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 59,000 2012-12-31 2012 FY 10-K 2013-03-13 0001193125-13-104455
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.1 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 150,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap OtherAccruedLiabilitiesCurrentAndNoncurrent Other Accrued Liabilities USD 137,500 2012-09-30 2012 Q3 10-Q 2012-11-06 0001193125-12-453634
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 2.01M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-19 0001108205-20-000003
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-09 0001108205-21-000012
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -18,806 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-13 0001193125-13-104455
us-gaap OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) USD -11,397 2011-01-01 2011-12-31 2011 FY 10-K 2012-02-29 0001193125-12-089082
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 2,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-19 0001108205-20-000003
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap OtherIncome Other Income USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-26 0001108205-19-000004
us-gaap OtherLaborRelatedExpenses Other Labor-related Expenses USD 494,616 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-12 0001193125-13-437655
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2021-12-31 2021 FY 10-K 2022-02-24 0001108205-22-000002
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-01 0001108205-18-000017
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-13 0001108205-23-000023
us-gaap PaidInKindInterest Paid-in-Kind Interest USD -713,968 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-24 0001193125-15-060006
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 123,000 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-10-31 0001193125-11-288471
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-26 0001108205-19-000004
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.53M 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-24 0001108205-22-000002
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 30.00M 2015-02-01 2015-02-28 2015 Q3 10-Q 2015-11-09 0001193125-15-371270
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap PaymentsToAcquireLongtermInvestments Payments to Acquire Long-term Investments USD 750,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-06 0001193125-12-453634
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 93.13M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001108205-22-000002
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-08 0001108205-24-000010
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001108205-26-000118
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 1.36M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 30.00M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-13 0001193125-13-104455
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 2.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries Proceeds from Divestiture of Interest in Consolidated Subsidiaries USD 2.50M 2025-11-01 2025-11-30 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 18.66M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001108205-26-000118
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001108205-22-000002
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 2.50M 2026-01-01 2026-01-31 2026 Q2 10-Q 2026-08-14 0001108205-26-000118
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 185,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0001108205-23-000074
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 24.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ProceedsFromLongTermLinesOfCredit Proceeds from Long-term Lines of Credit USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-26 0001108205-19-000004
us-gaap ProceedsFromRepaymentsOfDebt Proceeds from (Repayments of) Debt USD -929,339 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-07 0001193125-15-176676
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap ProceedsFromSaleOfMachineryAndEquipment Proceeds from Sale of Machinery and Equipment USD 0 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-03 0001628280-16-020671
us-gaap ProceedsFromSaleOfOtherPropertyPlantAndEquipment Proceeds from Sale of Other Property, Plant, and Equipment USD 1,750 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-10 0001193125-14-404759
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001108205-18-000005
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 375,661 2012-01-01 2012-09-30 2013 Q3 10-Q 2013-11-12 0001193125-13-437655
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -40.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 913,000 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 36,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 0 2020-06-01 2021-12-31 2021 FY 10-K 2022-02-24 0001108205-22-000002
us-gaap RepaymentsOfDebt Repayments of Debt USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001108205-22-000002
us-gaap RepaymentsOfLongTermLinesOfCredit Repayments of Long-term Lines of Credit USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001108205-22-000002
us-gaap ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned Research and Development Arrangement, Contract to Perform for Others, Compensation Earned USD -70,000 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-07 0001108205-17-000017
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 18.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 13.16M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001108205-26-000118
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001108205-18-000005
us-gaap RestrictedCash Restricted Cash USD 544,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 544,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 544,000 2025-12-31 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap RestrictedInvestments Restricted Investments USD 200,000 2019-09-30 2019 Q3 10-Q 2019-11-05 0001108205-19-000020
us-gaap RestrictedInvestmentsCurrent Restricted Investments, Current USD 0 2020-09-30 2020 Q3 10-Q 2020-11-10 0001108205-20-000016
us-gaap RestrictedInvestmentsNoncurrent Restricted Investments, Noncurrent USD 0 2019-09-30 2019 Q3 10-Q 2019-11-05 0001108205-19-000020
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.29B 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 8.30M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 6.72M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-05 0001108205-19-000020
us-gaap Revenues Revenues USD 2.47M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001108205-18-000010
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001108205-22-000002
us-gaap RoyaltyExpense Royalty Expense USD 45,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap RoyaltyGuaranteesCommitmentsAmount Royalty Guarantees, Commitments, Amount USD 34.10M 2023-12-31 2024 FY 10-K 2025-03-31 0001108205-25-000031
us-gaap RoyaltyRevenue Royalty Revenue (Deprecated 2018-01-31) USD 2.47M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001108205-18-000010
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001193125-16-484817
us-gaap SecurityDeposit Security Deposit USD 200,000 2017-09-30 2017 Q3 10-Q 2017-11-07 0001108205-17-000017
us-gaap SeveranceCosts1 Severance Costs USD 300,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-19 0001108205-20-000003
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 3,962 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 62.6 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 2.14M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-13 0001108205-23-000023
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.33 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001108205-21-000003
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 5,239 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 62.6 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 3,669 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 62.6 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.13 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.14 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 1.13 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.043 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.044 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.039 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001108205-18-000005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 375,687 2026-06-30 2026 Q2 10-Q 2026-08-14 0001108205-26-000118
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001108205-26-000118
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 66,469 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 455.72 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-02 0001108205-23-000074
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 561,907 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001193125-16-484817
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 15,940 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 64.58 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-08 0001108205-24-000010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 115,987 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0001108205-23-000074
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 400,000 2014-06-03 2014-06-30 2017 FY 10-K 2018-03-08 0001108205-18-000005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 349,574 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 4.53 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001108205-26-000118
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 455,168 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 77.96 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 77.96 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001108205-26-000118
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 455,168 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 47.58 2023-12-31 2023 FY 10-K 2024-02-08 0001108205-24-000010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (Deprecated 2013-01-31) USD 1.29M 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-09 0001193125-13-210189
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 2.70M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001108205-21-000003
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-09 0001108205-17-000006
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 1.04M 2014-01-01 2014-12-31 2017 FY 10-K 2018-03-08 0001108205-18-000005
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001108205-26-000118
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 3.63 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001193125-16-484817
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 423.12 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 5.29 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 2.53 2013-09-30 2013 Q3 10-Q 2013-11-12 0001193125-13-437655
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 7.13M 2013-09-30 2013 Q3 10-Q 2013-11-12 0001193125-13-437655
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 10.53M 2013-09-30 2013 Q3 10-Q 2013-11-12 0001193125-13-437655
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 2.86 2013-09-30 2013 Q3 10-Q 2013-11-12 0001193125-13-437655
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionExpense Share-based Goods and Nonemployee Services Transaction, Expense (Deprecated 2013-01-31) USD 16,240 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-09 0001193125-13-210189
us-gaap SharePrice Share Price USD/shares 1.76 2016-09-06 2017 FY 10-K 2018-03-08 0001108205-18-000005
us-gaap ShortTermInvestments Short-term Investments USD 75.88M 2021-09-30 2021 Q3 10-Q 2021-11-09 0001108205-21-000012
us-gaap StateAndLocalIncomeTaxExpenseBenefitContinuingOperations State and Local Income Tax Expense (Benefit), Continuing Operations USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-29 0001193125-16-484817
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 0 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001108205-26-000118
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 2.55M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.05 2026-07-06 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 0 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001108205-21-000006
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 25.09M 2015-03-01 2015-03-02 2017 FY 10-K 2018-03-08 0001108205-18-000005
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited Stock Issued During Period, Shares, Restricted Stock Award, Forfeited shares 2,500 2023-07-01 2023-09-30 2023 Q3 10-Q 2023-11-02 0001108205-23-000074
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 17.97M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-08 0001108205-18-000005
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 2.26M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan Stock Issued During Period, Value, Employee Stock Ownership Plan USD 77,000 2025-04-01 2025-06-30 2025 Q2 10-Q 2025-08-05 0001108205-25-000080
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 1,000 2026-01-01 2026-03-31 2026 Q2 10-Q 2026-08-14 0001108205-26-000118
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 964,000 2012-01-01 2012-12-31 2014 FY 10-K 2015-02-24 0001193125-15-060006
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 0 2026-01-01 2026-03-31 2026 Q2 10-Q 2026-08-14 0001108205-26-000118
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 135,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001108205-22-000002
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures Stock Issued During Period, Value, Restricted Stock Award, Forfeitures USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001108205-25-000031
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-19 0001108205-20-000003
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 1,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 0 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-13 0001108205-23-000023
us-gaap StockRepurchaseProgramAuthorizedAmount Stock Repurchase Program, Authorized Amount (Deprecated 2014-01-31) USD 3.00M 2002-05-30 2002-05-31 2013 FY 10-K 2014-03-13 0001193125-14-097662
us-gaap StockRepurchaseProgramAuthorizedAmount1 Stock Repurchase Program, Authorized Amount USD 3.00M 2019-12-31 2019 FY 10-K 2020-03-19 0001108205-20-000003
us-gaap TreasuryStockRetiredCostMethodAmount Treasury Stock, Retired, Cost Method, Amount USD 0 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-19 0001108205-20-000003
us-gaap TreasuryStockShares Treasury Stock, Shares shares 0 2018-12-31 2018 FY 10-K 2019-03-26 0001108205-19-000004
us-gaap TreasuryStockSharesAcquired Treasury Stock, Shares, Acquired shares 244,569.2 2002-01-01 2018-02-28 2019 FY 10-K 2020-03-19 0001108205-20-000003
us-gaap TreasuryStockSharesRetired Treasury Stock, Shares, Retired shares 244,569.2 2018-03-01 2018-03-31 2019 FY 10-K 2020-03-19 0001108205-20-000003
us-gaap TreasuryStockValue Treasury Stock, Value USD 0 2018-12-31 2018 FY 10-K 2019-03-26 0001108205-19-000004
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 1.50M 2002-01-01 2018-02-28 2019 FY 10-K 2020-03-19 0001108205-20-000003
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 1.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001108205-26-000043
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 716,786 2013-12-31 2014 FY 10-K 2015-02-24 0001193125-15-060006
us-gaap WarrantsNotSettleableInCashFairValueDisclosure Warrants Not Settleable in Cash, Fair Value Disclosure USD 615,859 2012-12-31 2014 FY 10-K 2015-02-24 0001193125-15-060006
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 5.78M 2012-01-01 2012-03-31 2013 Q1 10-Q 2013-05-09 0001193125-13-210189
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 2.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 48.67M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001108205-21-000003
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 2.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001104659-26-127050

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →